The uptake of transferrin and iron by the rat liver was studied after intravenous injection or perfusion in vitro with diferric rat transferrin labelled with 1251 and 59Fe. It was shown by subcellular fractionation on sucrose density gradients that '251-transferrin was predominantly associated with a low-density membrane fraction, of similar density to the Golgi-membrane marker galactosyltransferase. Electron-microscope autoradiography demonstrated that most of the 1251-transferrin was located in hepatocytes. The 59Fe had a bimodal distribution, with a larger peak at a similar low density to that of labelled transferrin and a smaller peak at higher density coincident with the mitochondrial enzyme succinate dehydrogenase.
INTRODUCTION
The liver has a high capacity for iron exchange with plasma transferrin. Only the erythroid marrow and the chorioallantoic placenta are more active (Morgan, 1981) . In the rat 10-20% of the plasma iron turnover is directed to the liver (Mazur et al., 1960; Cheney et al., 1967; Gardiner & Morgan, 1974) . Most or all of this is due to uptake by the hepatocytes (Hershko et al., 1973) . Despite the quantitative importance of hepatocytes in iron metabolism, the mechanism by which they acquire iron from plasma transferrin is poorly understood. There is evidence to support two types of processes, namely (1) a specific receptor-mediated process and (2) non-specific processes.
The fenestrated nature of liver sinusoid allows ready entry of plasma proteins into the space of Disse with the possibility of direct interaction between transferrin and the hepatocyte cell membrane. Several investigators have reported that transferrin binds to a limited number of specific high-affinity binding sites (receptors) on the membranes of cells present in rat liver-cell suspensions, the number of sites varying from 25000 to 162000 per cell in the different reports (Grohlich et al., 1977; Young & Aisen, 1980; Cole & Glass, 1983; Morley & Bezkorovainy, 1983; Thorstensen & Romslo, 1984a; Tei et al., 1984) . However, other workers were unable to obtain evidence for receptors in cell suspensions prepared in a similar manner (Sibille et al., 1982; Soda & Tavassoli, 1984) .
Hence the question of the presence of transferrin receptors on hepatocytes is open to debate, and, if they exist, the mechanism by which they mediate iron exchange is uncertain. It is possible that this is by receptormediated endocytosis, as in developing erythroid cells (Morgan, 1981) and in several transformed cell lines in culture, including hepatoma cells (Ciechanover et al., 1983) . However, evidence for this in normal hepatocytes is lacking. Previous studies using subcellular-fractionation techniques failed to provide any evidence for endocytosis of transferrin (Milsom & Batey, 1979; Batey et al., 1980) . The possibility that iron uptake from transferrin is mediated by non-specific processes as well as by transferrin receptors is supported by experiments with liver-cell suspensions or cultured hepatocytes in which transferrin and iron uptake by the cells were found to increase linearly as the transferrin concentration was raised above that required to saturate the transferrin receptors (Sibille et al., 1982; Cole & Glass, 1983; Page et al., 1984) . Two mechanisms for this effect have been proposed, namely fluid-phase endocytosis and mediation by low-Mr chelators. The first undoubtedly occurs, but can account for less than 10% ofthe observed iron uptake (Cole & Glass, 1983; Page et al., 1984) . The second is supported by observations that liver cells rapidly take up iron complexed to citrate or other chelators (Mazur et al., 1960; Charley et al., 1960; Grohlich et al., 1977 Grohlich et al., , 1979 Zimelman et al., 1977) . Whether or not similar mechanisms are involved in the uptake of transferrinbound iron is unknown.
The aim of the present research was to investigate the mechanism of iron exchange between transferrin and the liver in the rat by using a subcellular-fractionation procedure to monitor the binding, endocytosis and subcellular distribution of iron and transferrin. The livers were fractionated after either intravenous injection or short-term perfusion with transferrin labelled with 59Fe and 1251 or 1311 The results show that transferrin is endocytosed into a low-density-vesicle fraction of the cells and that the uptake of transferrin and iron by the cells is dependent on two specific processes, one saturable at low concentrations of transferrin and the other non-saturable up to transferrin concentrations of at least 10 /zM. Both processes involve endocytosis of transferrin.
METHODS

Materials
Rat transferrin was isolated from plasma as previously described (Morgan, 1979) . It was a mixture of the 'fast' and 'slow' forms, which have been shown to donate iron equally to the liver and to other tissues in the rat (Huebers et al., 1978) . Rat liver ferritin was isolated by the method of Huebers et al. (1976) . Rat serum albumin and bovine serum albumin were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.) and pig insulin (Monotard MC) was from Novo (Basingstoke, Hants., U.K.). Chloroquine, methylamine and digitonin were from Sigma Chemical Co. The radioactive isotopes (59Fe as FeCl3, 1251 and 131I as Nal) were obtained from Amersham International (Amersham, Bucks., U.K.). Anti-(rat transferrin) serum and anti-(rat ferritin) serum were obtained from rabbits given three intramuscular injections of rat transferrin or rat ferritin emulsified with Freund's complete adjuvant at 2-week intervals.
Labelling of proteins
Transferrin was saturated with iron and labelled with 59Fe as in previous experiments (Hemmaplardh & Morgan, 1974) before the labelling with radioiodine. The proteins (transferrin, rat serum albumin and bovine serum albumin) were labelled with 125I or 131I by the ICI method (McFarlane, 1963) to a maximum extent of I iodine atom per protein molecule. Unbound radioiodine was removed by passage through an anion-exchange column (IRA 410) followed by dialysis against three changes of 0.15 M-NaCl. Previous studies have shown that rat transferrin and albumin labelled by these methods are not denatured and show no evidence of increased rates of catabolism when injected into rats (Morgan, 1966) . Insulin was labelled with 1251 by the lactoperoxidase method, and the A14-labelled derivative was isolated by h.p.l.c. as previously described (Christensen et al., 1985) .
Intravenous injections
In some experiments rats were injected intravenously with 0.8 mg of 59Fe-1251-transferrin at given times before the livers were removed and fractionated as described below. The injections were usually performed via a lateral tail vein with the animals under light anaesthesia induced with Penthrane (Abbott Laboratories, Queenborough, Kent, U.K.). In one experiment the injection was made into the portal vein with the rat anaesthetized with an intraperitoneal injection of sodium pentobarbitone. For removal of the livers the rats were anaesthetized with sodium pentobarbitone and each liver was perfused through the portal vein with ice-cold phosphate-buffered saline (150 mM-NaCl/ 1O mM-sodium phosphate buffer, pH 7.4) for 2.5 min. The liver was then removed and weighed, and a sample was homogenized and fractionated by sucrose-density-gradient centrifugation as described below. Perfusion studies Rat livers were perfused in a non-circulating system with Krebs-Henseleit bicarbonate Ringer solution containing glucose (50 mM) and bovine serum albumin (0.5 g/100 ml) as previously described . After a 'pre-perfusion' period of 2 min the perfusion solution was changed to one containing radiolabelled transferrin and the perfusion was continued for various times. The liver was then 'post-perfused' with the Krebs-Ringer medium alone for 2.5 min unless otherwise specified. The perfusates were saturated with 02/CO2 (19: 1). The temperature of the perfusate was 37°C, except for one perfusion, when a temperature of 4°C was used. The effluent perfusion fluid was collected over 15 s or 30 s intervals during the perfusion and post-perfusion periods.
Liver fractionation
Portions of the liver weighing 2.0 g were homogenized with 10.0 ml of ice-cold 0.25 M-sucrose in 20 mMethanol/1O mM-Hepes/NaOH buffer, pH 7.4, with ten strokes of pestle A and ten strokes of pestle B in a 15 ml Dounce homogenizer (Kontes Glass Co., Vineland, NJ, U.S.A.). The homogenate was filtered through a 50 #m nylon mesh. A 5 ml portion was then fractionated by analytical density-gradient centrifugation on a linear sucrose gradient in a Beaufay automatic zonal rotor . From this 15 or 16 fractions were collected, weighed and their densities determined indirectly by refractometry. Samples from each fraction were assayed for enzyme activities, total protein and transferrin concentrations, and for trichloroacetic acidsoluble and -precipitable radioactivity. Radioactivity measurements were also made on the plasma (in the intravenous injection experiments) or the perfusate and effluent perfusion solutions (in the liver perfusion experiments).
Autoradiography
The cellular distribution of diferric 1251-transferrin in the liver was examined by electron-microscope autoradiography in two experiments, one in a perfused liver and one in vivo. In the first, a liver was perfused with 1251-transferrin (0.25 /SM) for 8 min followed by postperfusion for 2.5 min, and, in the second, liver samples were taken 1, 4, 9 and 20 min after intravenous injections of 0.5 mg of labelled transferrin. Small samples of the livers were fixed in 2.5% (w/v) glutaraldehyde in 0.1 M-cacodylate buffer, pH 7.2, for 2 h at 4°C and post-fixed with 1% (w/v) Os04 in the same buffer for 1 h at room temperature. The tissue was then prepared for electron-microscope autoradiography as previously described (lacopetta & Morgan, 1983 Marker enzymes were assayed as described by . Protein was measured by a modified Lowry procedure (Shacterle & Pollack, 1973) , with bovine serum albumin as standard. Transferrin was determined by radial immunodiffusion (Mancini et al., 1965) after treatment of homogenates or fractions with Triton X-100 (0.5 %, v/v) to release the protein from cellular organelles.
Trichloroacetic acid-precipitable radioactivity was determined by precipitation with an equal volume of ice-cold 20% (w/v) trichloroacetic acid followed by centrifugation at 1500 g for 30 min. Radioactivity was counted in a two-channel y-radiation scintillation counter (LKB Wallac).
Computation
Frequency-density histograms were constructed by the method of Leighton et al. (1968) . Frequency is defined as the ratio of the activity in a fraction to the total activity in the gradient divided by the density span of that fraction. Relative frequency is defined as the product of the frequency and the relative specific activity of the activities in the total homogenates. The data were also processed by a suitable computer program to calculate the activity between defined density boundaries.
RESULTS
Subcellular fractionation after liver perfusion
Transferrin, 1251, 59Fe and several marker enzymes were determined in the sucrose-density-gradient fractions obtained after fractionation of livers that had been perfused with 125I-59Fe-transferrin for 5 min. The mean results from six gradients, plotted as frequency-distribution histograms, are presented in Fig. 1 . Both 1251 and 59Fe have bimodal distributions. Approx. 70% of the 1251 is in a low-density peak (1.13 g/cm3), which is coincident with that ofthe Golgi-membrane marker galactosyltransferase ( Fig. 1 ) and also with latent phosphodiesterase (results not shown). A smaller 1251 peak is discernible at 1.18-.1.19 g/cm3, the same density as that of the plasma-membrane marker 5'-nucleotidase. More than 97% of the 125I in the fractions of density 1.10 g/cm3 and greater was precipitated with trichloroacetic acid, but in the less-dense fractions 5-10% of the 1251 was soluble in trichloroacetic acid. The distribution of 125I-transferrin in the gradient differs from that of immunologically assayed endogenous transferrin, which was broadly distributed between 1.15 and 1.25 g/cm3, corresponding to the density of the endoplasmic-reticulum marker enzyme neutral a-glucosidase. The larger of the two 59Fe peaks has a modal density similar to that of the major 1251 peak, but the smaller 59Fe peak has a greater density The results in Fig. 1 are the means for six perfusions. When the individual gradients Were exami-fed it was found that the 59Fe distribution was more closely mirrored by succinate dehydrogenase than,by N-acetylfl-glucosaminidase. This is illustrated fn Fig 2(a) . In every gradient succinate dehydrogenase and the smaller 59Fe peak had almost identical distributions, while the more broadly distributed N-acetyl-,f-glucosaminidase extended into a more-dense region of the gradient. Also shown in Fig. 2 (Fig. 2b) are the results expressed as the ratio of pmol of iron to pmol of transferrin found in each fraction. The pattern is typical of that observed with the other five perfusions. The Fe/transferrin molar ratio was greater than 2:1 (the ratio in the perfusion solution) throughout most of the gradient, but was consistently found to be less than 2:1 (1.4-1.9:1) in the low-density peak of 1251-transferrin activity.
The 59Fe in the gradient fractions differed from that in the perfusion solution with respect to its precipitability by trichloroacetic acid and with anti-(rat transferrin) and anti-(rat ferritin) sera. The 59Fe in the perfusion solution was precipitated by anti-transferrin serum but not by Vol. 237 The results are from one gradient and show iron uptake in terms of pmol/ml of each subcellular fraction, calculated from the radioactivity of the fractions and the specific radioactivity of the iron in the perfusion solution. This solution contained 0.1 u/M diferric transferrin. Table 1 . Precipitation of 59Fe with anti-transferrin serum, anti-ferritin serum and trichloroacetic acid Sucrose-density-gradient fractions and perfusion solution from experiments in which the liver was perfused for 5 min with radiolabelled transferrin were treated with antisera to transferrin and ferritin and with 10% trichloroacetic acid as described in the text. The results are expressed as the percentage of 59Fe present in the samples that was precipitated by these procedures.
Each value is the mean + S.E.M. for six separate perfusions.
5"Fe in precipitate (% of total radioactivity) Anti-transferrin anti-ferritin serum, and was about 95% soluble in trichloroacetic acid (Table 1 ). In contrast, only about 20% ofthe radioactivity in either ofthe two 59Fe gradient peaks was precipitated with anti-transferrin serum whereas 85% was precipitated with trichloroacetic acid. Approx. 50% of the radioactivity in the lower-density 59Fe peak, but only 6% in the more-dense peak, was precipitated with anti-ferritin serum. Hence most of the 59Fe in the liver-cell fractions was free of transferrin and approx. 50 % of that in the lower-density peak had been incorporated into ferritin during the 7.5 min perfusion plus post-perfusion period used in these studies. Effect of digitonin on the density of transferrin-rich fractions A liver was perfused with 59Fe-1251-transferrin (0.25 /tM) for 5 min and post-perfused for 2.5 min, and portions were homogenized in the usual 0.25 M-sucrose/Hepes solution or in the same solution containing 1.0 mg of digitonin/ml. As shown in Fig. 3 , the digitonin caused a shift in the 591-transferrin peak to a more-dense region of the gradient (median density 1.20 g/cm3). This was associated with a smaller shift in the density of the Golgi-membrane marker enzyme galactosyltransferase, so that it was no longer coincident with the distribution of 125I-transferrin. Injection of 59Fe-'251-transferrin in vivo
In preliminary studies it was found that the uptake and distribution of 59Fe and 1251 in the liver subcellular fractions were similar when the labelled transferrin was injected by the portal vein or by a tail vein. Moreover, the subcellular distributions of the labels were similar to that observed after perfusions in vitro. Hence the perfusion technique was used to investigate uptake during the first 15 min and injection by a tail vein was used in an experiment aimed at studying the uptake oftransferrin and iron over time periods from 5 to 135 min. A liver-was perfused with 0.25 ,uM radiolabelled rat transferrin for 5 min, then post-perfused for 2.5 min, and portions were homogenized in the presence (fine line) or in the absence (bold line) of digitonin (1 mg/ml) before fractionation by sucrose-density-gradient centrifugation. The results for liver 125I show total radioactivity as percentage of injected dose in uncorrected form (0) and after correction for the fall in plasma 1251 radioactivity (U). The results for 59Fe show total radioactivity (0) and also the radioactivity in the fractions with density boundaries,of 1.10-1.16 g/cm3 (A) and 1.16-1.25 g/cm3 (*).
Time course of transferrin and iron uptake
As shown in Fig. 4 , the plasma concentration of 59Fe declined rapidly after intravenous injection of 59Fe-1251-transferrin whereas that of 1251 decreased more slowly. Uptake of 1251 by the liver was rapid, reaching maximal values within 5-15 min. In contrast, 59Fe uptake continued in an approximately linear fashion for the duration of the experiment (135 min) and by then amounted to 13 % of the injected amount ofthe label. The relative distribution of 125I between the subcellular fractions did not change with time. However, with 59Fe there was a more rapid increase in the radioactivity in the lower-density peak than in the higher-density peak after the 15 min time point (Fig. 4) .
Perfusion studies for times varying from 2 to 15 min confirmed the rapid uptake of transferrin by the liver and its equally rapid appearance in the subcellular fractions. By 5 min near-maximal values were found for total. uptake of 1251-transferrin and for 1251-transferrin in the low-density peak. transferrin led to a different picture (Fig. 6b) . The lect of transferin concentration on transferrin and iron distribution patterns of the two proteins in the density ptake by the perfused rat liver gradient were very similar, both being found in maximal rers were perfused for 5 min with diferric transferrin concentrations in the same low-density membrane indicated concentrations. The Fiiure shows total fractions. uptake (0) and uptake into the fractions with density boundaries of 1.10-1.16 g/cm3 (0) and 1.16-1.25 g/cm3 (U). The inset shows iron uptake into these two fractions at transferrin concentrations up to 1.25 #M.
time but there was little change in the relative distribution of the 59Fe between its two peaks. Effect of transferrin concentration Livers were perfused for 5 min with radiolabelled diferric transferrin at concentrations ranging from 0.025 to 1O/tM. As the concentration was raised the uptake of both transferrin and iron increased rapidly in a curvilinear fashion until the transferrin concentration reached about 1 ,UM and thereafter more slowly in a linear manner (Fig. 5) . The amount of transferrin uptake into the low-density peak showed a similar pattern ofincrease, although the percentage oftotal uptake found in this peak decreased progressively as the transferrin concentration was raised, from 70% at 0.025 1sM-transferrin to 53 % when the concentration was 10,M. Nevertheless, transferrin uptake into the low-density peak increased 2.5-fold as the transferrin concentration was raised from 1.0 to 1O/tM. Over the same concentration range iron uptake increased 2.8-fold. At transferrin concentrations below 0.5 /LM relatively more of the iron uptake was directed to the lower-density 59Fe peak, but at higher transferrin concentrations iron incorporation into the higher-density peak predominated (Fig. 5 inset) .
The total transferrin-uptake data in Fig. 5 were analysed by a non-linear curve-fitting program (Munson & Rodbard, 1980) to assess the affinity and number of binding sites for transferrin in the liver. The experimental Effect of perfusion at 4°C When a 5 min perfusion was performed with the medium and perfusion chamber at 4°C transferrin and iron uptakes by the liver were markedly decreased compared with perfusion at 37°C, there was negligible uptake into the fractions of density 1.10-1.15 g/cm3, but some transferrin and iron were associated with a more-dense region of the gradient from 1.15 to 1.21 g/cm3 (Fig. 7a) . This corresponds to the distribution of 5'-nucleotidase (Fig. 1) . Release of transferrin and iron from the liver In order to investigate whether the transferrin and iron taken up during a 5 min perfusion period could be released from the liver, four perfusions were performed with a 20 min post-perfusion period instead of the standard 2.5 min. Non-radioactive diferric transferrin was added to the post-perfusion solution at a concentration of 1.25 gm in two of these perfusions but was not included in the other two. The results from one each of these two types of perfusions are illustrated in Figs. 7(b) and 8. The other perfusions gave similar results. The concentrations of59Fe and 1251 in the post-perfusion fluids fell rapidly during the first 2 min as the radioactive perfusate was washed out of the liver (Fig. 8) . After that time there were differences with respect to the two radioisotopes and to whether or not transferrin was added to the post-perfusion solution. In each case the concentration of 1251 in this solution was greater than that of59Fe, the difference being greater when non-radioactive transferrin was added to the solution. After post-perfusion for 8-10 min without added transferrin the concentrations of 59Fe and 125I in the solutions stabilized and thereafter Subcellular fractionation of the liver after 20 min postperfusion showed that there had been a marked decline in hepatic 125I and a lesser decline in 59Fe (Fig. 7b) . The total 1251 values fell to 46 and 18% and the 59Fe values to 70 and 61 % of the control values with transferrin-free and transferrin-added post-perfusate solutions respectively. Release of transferrin from the low-density-vesicle fraction Portions of the liver from the experiment described above were homogenized in the standard manner and a low-density-vesicle fraction was prepared by centrifugation in a discontinuous sucrose density gradient as described previously . The vesicle fraction was suspended in 0.25 M-sucrose/Hepes, pH 7.4, and was divided into four aliquots. The pH of two aliquots was adjusted to 5.2 by the addition of 0.1 M-HCI, and the detergent Brij 35 (Sigma Chemical Co.) was added to a concentration of 1 mg/ml to one aliquot at each pH value (7.4 and 5.2). The four samples were then centrifuged at 100000 g for 1 h. Radioactivity was counted in the supernatant and sedimented fractions. The entire procedure was performed at 4 'C. At pH 7.4 the addition of Brij 35 caused an increase in the release of 1251-transferrin into the supernatant fraction from 20% to 61 %. However, at pH 5.2 transferrin release in the absence of Brij was decreased to about 13%, and to an even lower value in its presence (7.1 %).
Autoradiography
In both experiments the majority of the autoradiography grains were found to lie over hepatocytes, with few over endothelial cells and virtually none on Kupffer cells. Examination of the autoradiographs from the liver that had been perfused with 1251-transferrin for 8 min showed 127 grains in 114 hepatocytes but only three grains in 53 endothelial cells. The distribution of grains in the experiment conducted in vivo is summarized in Table 2 . As early as 1 min after the injection the majority of the grains were over hepatocytes and at no time were more than 10% found over endothelial cells. Furthermore, many of the grains scored as being in the sinusoids and space of Disse were over microvilli on the sinusoidal membrane of hepatocytes and probably indicate the location of transferrin molecules in the process of being taken up by hepatocytes.
DISCUSSION
Radioiodinated transferrin was rapidly taken up by the liver and was localized mainly into a low-density membrane fraction of the cells. This fraction has been shown to contain large and small vesicles and tubular elements, many of which have the appearance of being Vol. 237 derived from the Golgi complex . The fractions enriched with '251-transferrin contained the Golgi-membrane marker enzyme galactosyltransferase, but could be partly differentiated from that enzyme marker by treatment with digitonin. These properties are similar to those attributed to ligandosomes, membranes implicated in the intracellular processing of insulin, glucagon and prolactin Smith & Peters, 1982; Bassett et al., 1984) . However, it is not known whether transferrin is translocated to exactly the same membranes as the polypeptide hormones, although the density distributions of transferrin and insulin were found to be extremely similar. The ultimate fates of transferrin and the hormones are very different, transferrin being released from the cells with little-evidence of degradation, whereas insulin is extensively degraded.
In the present work the 1251-transferrin-rich fractions are referred to as 'low-density vesicles'. The results of the autoradiographic studies show that most of the transferrin taken up by the liver was in hepatocytes, not in Kupffer cells or sinusoidal endothelial cells. This is compatible with previous work that demonstrated that transferrin-bound iron taken up by the liver is incorporated almost exclusively into hepatocytes (Hershko et al., 1973) but is in disagreement with a report that transferrin binds only to endothelial cells (Soda & Tavassoli, 1984) . The latter conclusion was based on studies with suspensions of isolated rat liver cells. At least two explanations can be advanced for the apparent conflict between the results obtained in that work and in the present investigation. Firstly, transferrmnmay bind -to endothelial cells in the intact liver and be transported to the space of Disse, from which it can be taken up by hepatocytes. Alternatively, the procedures used in the preparation of the suspensions of isolated liver cells may have damaged the hepatocytes so that they could no longer bind transferrin. For the first explanation to be correct it would be necessary to assume that transport through the endothelial cells is very rapid, since 1251-transferrin was found predominantly in hepatocytes as early as 1 min after intravenous injection, and that it leads to a modification of the transferrin molecule so that it becomes able to bind to hepatocytes. The alternative explanation requires that the transferrin receptors on endothelial cells are more resistant to damage than are those on hepatocytes or that the observed binding of transferrin to the endothelial cells is non-specific in nature. With respect to the latter possibility it may be noted that hepatic endothelial cells have been shown to bind non-specifically and endocytose many ligands (Ghitescu & Fixman, 1984) . Several lines of evidence indicate that transferrin was incorporated into the low-density vesicles by receptormediated endocytosis. The density distribution of transferrin was the same as that of insulin and that described for glucagon , both of which have been shown by electron-microscope autoradiography to be taken into hepatocytes by receptor-mediated endocytosis (Bergeron et al., 1977 (Bergeron et al., , 1979 Carpentier et al., 1979) . The time course of incorporation of transferrin into the low-density vesicles at 37°C and inhibition ofthis process at 4°C are characteristic properties of receptormediated endocytosis ofmany ligands by a variety ofcells (Neville & Chang, 1978) , including transferrin endocytosis by immature erythroid cells (Morgan & Appleton, 1969; lacopetta & Morgan, 1983) . In addition to the 1251-transferrin present in the low-density vesicle fractions, smaller amounts were found in the soluble fraction of the cell and in fractions corresponding to the plasma-membrane marker. The former probably represents transferrin released from membrane components during homogenization, and the latter probably represents transferrin bound to receptors present on the plasma membrane. Very little 1251_ transferrin was found in the lysosome-containing fractions, and the proportion of cell-associated labelled transferrin in these fractions did not increase with time. Hence it may be concluded that little or none of the endocytosed transferrin is translocated to lysosomes. This may account for the very low degree of transferrin degradation.
The intracellular distribution of endocytosed transferrin was different from that of endogenous transferrin. The latter is synthesized and secreted by the hepatocytes and has been shown to accumulate in the microsomal fraction of the liver (Morgan & Peters, 1971 ). The present results indicate that it is mainly in the endoplasmic reticulum, with little in the Golgi complex.
Iron was released from transferrin and accumulated by the liver into two broad peaks, probably corresponding to ferritin and mitochondria. The identity of the first of these peaks is indicated by the precipitability of a large proportion of the 59Fe with anti-ferritin serum and the fact that its density distribution is the same as that observed for soluble ferritin added to liver homogenates (Selden et al., 1980) . The close correspondence between the density distribution of succinate dehydrogenase and Vol. 237 the second 59Fe peak supports the suggestion that it is due to iron accumulation in mitochondria, although further work is required to confirm this. When the molar ratio of iron and transferrin uptake into the different density fractions was examined it was consistently found to be lower than 2:1 in the low-density membrane fractions. Hence it is probable that iron is released from transferrin while in the low-density vesicles. Possible this is due to acidification of the vesicles, as has been shown to be the case in immature erythroid cells (Paterson et al., 1984) and transformed cells (van Renswoude et al., 1982) .
The effects of increasing concentrations of diferric transferrin in the perfusion solution on transferrin and iron uptake by the liver suggest that two processes are involved, one saturable at transferrin concentrations of 0.5-1.0 4tM and the other non-saturable within the range of concentrations tested. Similar conclusions have been reached in studies with liver-cell suspensions and cultured hepatocytes (Cole & Glass, 1983; Page et al., 1984) .
Both the saturable and the non-saturable iron-uptake processes led to transferrin incorporation into lowdensity vesicles from which rat serum albumin and bovine serum albumin were excluded. Hence both of the transferrin-uptake processes show specificity, probably due to interaction with specific binding sites or receptors on the cell membrane. Also, both led to iron accumulation by the cells. Analysis of the transferrin-uptake data by a non-linear curve-fitting program indicated that they best fitted a model based on transferrin binding to a limited number of high-affinity receptors plus 'non-specific' binding. The latter component of the model is due to the non-saturable binding of transferrin at concentrations above 1 UM. However, the fact that transferrin uptake into the low-density vesicles and iron uptake increased more than 2-fold as the transferrin concentration was raised from 1 to 10 /tM, although albumin was excluded from the vesicles, indicates that the term 'non-specific' is not applicable. It would be better to refer to this component of the uptake process as low-affinity specific uptake. Whether or not it is due to a finite number of binding sites that could be saturated at very high transferrin concentrations is unknown. However, because of the apparent lack of saturability it is not possible to calculate the affinity and number ofbinding sites involved in the low-affinity uptake of transferrin.
The apparent association constant of binding of transferrin to the high-affinity binding sites was calculated to be 5.2 x 106 M-1 and the number of sites was 57 pmol/g of liver. The properties of these receptors are similar to those of immature erythroid cells (Ecarot-Charrier et al., 1980; lacopetta et al., 1982; Morgan, 1983) (Seglen, 1973 Thorstensen & Romslo, 1984a; Tei et al., 1984) . The reasons for the differences between the present results and those in the literature are uncertain. They may reflect the different methods employed, but this is unlikely to account for the great differences observed, especially in the number of binding sites. One possible explanation is the same as that mentioned above, namely that during preparation of liver-cell suspensions the plasma membranes became damaged with loss and/or alteration of transferrin receptors. Thorstensen & Romslo (1984b) published evidence for the presence of high-affinity and low-affinity transferrin receptors on rat liver cells in suspension. Binding to the low-affinity sites could be prevented by inclusion of bovine serum albumin in the incubation medium at concentrations of 0.4-0.6 g/100 ml. Since bovine serum albumin was included in the perfusion solution used in the present work in this concentration range it is unlikely that the low-affinity binding is of the same nature as that described by Thorstensen & Romslo (1984b) .
Radioiodinated transferrin and a smaller proportion of the 59Fe were both released from the liver during post-infusion. After 20 min perfusion with a medium containing non-radioactive transferrin about 90% of the 125J had been released, mostly in a trichloroacetic acidand anti-transferrin-precipitable form. Hence most of the transferrin taken up by the liver appears to be recycled to the perfusion solution in a non-degraded form but with lower iron content. However, there was an increase in the percentage solubility of the 125I in trichloroacetic acid from 2% in the perfusion solution to 3-10% in the livercell fractions and 5 % in the post-perfusion solution, suggesting that a low degree of transferrin degradation occurs in its cycle through the liver cells. This is in keeping with previous observations on the rate of transferrin degradation by the perfused rat liver (Hoffenberg et al., 1970) .
Less transferrin and iron were released from the liver when the post-perfusion solution was free of added transferrin than when it was present. This may be due to rebinding and recycling of transferrin in the absence of added unlabelled transferrin to compete for the receptor sites.
The fact that some 59Fe was released from the liver is indicative of the reversible nature of iron exchange between this organ and plasma transferrin. It may also be due to incomplete release of iron from transferrin as the transport protein cycles through the low-density vesicles. As a result of previous studies with the perfused liver (Baker et al., 1980) and isolated hepatocytes (Baker et al., 1981 (Baker et al., , 1985 it was concluded that iron released from transferrin enters a labile compartment in the liver from which it can proceed to ferritin or other intracellular iron compounds, or be released from the cells to be rebound by transferrin. The results of the present investigation support this conclusion and indicate that iron in the labile pool may very quickly be incorporated into ferritin or into mitochondria.
Evidence for transferrin endocytosis by normal liver cells has not previously been reported, although some authors have assumed, without evidence, that they were dealing with such a process for studying isolated liver cells (Sibille et al., 1982; Young et al., 1983) . Previous studies using the subcellular-fractionation technique after intravenous injection of radiolabelled transferrin failed to provide any evidence for transferrin endocytosis or iron transport to mitochondria (Milsom & Batey, 1979; Batey et al., 1980) . The reasons for the discrepancies between these and the present results probably lie in the fractionation techniques that were employed. However, the pattern of results described in the present work was found in every fractionation of liver performed after perfusion with radiolabelled transferrin at 37°C or after intravenous injections. Moreover, the effects of temperature, of time and of post-perfusion and comparison with insulin and albumin all combine to indicate the validity of the present experiments and the conclusions based on the results obtained.
On the basis of the present investigation it may be concluded that the uptake of the transferrin-bound iron by the liver involves receptor-mediated endocytosis of the iron-transferrin complex to a low-density vesicle compartment of hepatocytes where the iron is released from transferrin. This is followed by recycling the transferrin to the cell membrane and its release into the perfusing solution or blood. There are both high-affinity and low-affinity transferrin receptors, the latter being present in very large numbers. Transferrin endocytosis and iron uptake follow binding to either type of receptor. As a consequence the rate of iron uptake by the liver increases as the iron-transferrin concentration is raised. This is probably the reason for the high degree of hepatic deposition ofiron and the susceptibility ofthe liver to iron overload in conditions associated with high concentrations of serum iron (Zimelman et al., 1977; Bothwell et al., 1979) .
